Mangoceuticals (MGRX) EBITDA Margin (2023 - 2026)
Mangoceuticals (MGRX) reported EBITDA Margin of 4606.75% for Q1 2026, down 42000.0% on a YoY basis from N/an in Q1 2025, and down 1082.07% sequentially from 389.72% in Q4 2025.
Mangoceuticals (MGRX) EBITDA Margin (2023 - 2026) Analysis & Trends
Mangoceuticals (MGRX) has 4 years of EBITDA Margin data on file, last reported at 4606.75% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin fell 42000.0% year-over-year to 4606.75%; the trailing twelve-month figure through Mar 2026 stood at 3933.02% (down 194103.0% YoY), and the FY2025 full-year result was 3954.28%, down 265986.0% from the prior year.
- EBITDA Margin eased to 4606.75% in Q1 2026, from 389.72% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 389.72% in Q4 2025 to a low of 8953.45% in Q3 2025.
- A 4-year average of 2505.12% and a median of 1594.02% in 2024 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin jumped 143491 bps in 2024 and sank 763524 bps in 2025, its largest moves.
- Tracing MGRX's EBITDA Margin over 4 years: stood at 1050.87% in 2023, then slumped by 52 bps to 1594.02% in 2024, then jumped by 76 bps to 389.72% in 2025, then plunged by 1082 bps to 4606.75% in 2026.
- Business Quant data shows MGRX's EBITDA Margin at 4606.75% in Q1 2026, 389.72% in Q4 2025, and 8953.45% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | 30.93% |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | 3.36% |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | 29.03% |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | 17.59% |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | -11.30% |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | -11.11% |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | 25.64% |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | 17.08% |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | 1.23% |
| 10 | Mangoceuticals | 9.39 Mn | 9.20 Mn | 29,001.00 | -4,606.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,606.75% |
| Dec 31, 2025 | -389.72% |
| Sep 30, 2025 | -8,953.45% |
| Jun 30, 2025 | -3,133.98% |
| Mar 31, 2025 | -4,186.75% |
| Dec 31, 2024 | -1,594.02% |
| Sep 30, 2024 | -1,318.21% |
| Jun 30, 2024 | -1,329.13% |
| Mar 31, 2024 | -1,105.87% |
| Dec 31, 2023 | -1,050.87% |
| Sep 30, 2023 | -733.99% |
| Jun 30, 2023 | -1,622.99% |
| Mar 31, 2023 | -2,540.78% |